﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>BioImpacts</JournalTitle>
      <Issn>2228-5652</Issn>
      <Volume>13</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2023</Year>
        <Month>05</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Fabrication of mesoporous silica nanoparticles for targeted delivery of sunitinib to ovarian cancer cells</ArticleTitle>
    <FirstPage>255</FirstPage>
    <LastPage>267</LastPage>
    <ELocationID EIdType="doi">10.34172/bi.2023.25298</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Mitra</FirstName>
        <LastName>Torabi</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-9012-4976</Identifier>
      </Author>
      <Author>
        <FirstName>Ayuob</FirstName>
        <LastName>Aghanejad</LastName>
      </Author>
      <Author>
        <FirstName>Pouria</FirstName>
        <LastName>Savadi</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-9387-082X</Identifier>
      </Author>
      <Author>
        <FirstName>Abolfazl</FirstName>
        <LastName>Barzegari</LastName>
      </Author>
      <Author>
        <FirstName>Yadollah</FirstName>
        <LastName>Omidi</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-0067-2475</Identifier>
      </Author>
      <Author>
        <FirstName>Jaleh</FirstName>
        <LastName>Barar</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-0105-919X</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/bi.2023.25298</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2022</Year>
        <Month>02</Month>
        <Day>25</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2022</Year>
        <Month>07</Month>
        <Day>23</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: Mesoporous silica nanoparticles (MSNPs) are considered innovative multifunctional structures for targeted drug delivery owing to their outstanding physicochemical characteristics. Methods: MSNPs were fabricated using the sol-gel method, and polyethylene glycol-600 (PEG600) was used for MSNPs modification. Subsequently, sunitinib (SUN) was loaded into the MSNPs, MSNP-PEG and MSNP-PEG/SUN were grafted with mucin 16 (MUC16) aptamers. The nanosystems (NSs) were characterized using FT-IR, TEM, SEM, DLS, XRD, BJH, and BET. Furthermore, the biological impacts of MSNPs were evaluated on the ovarian cancer cells by MTT assay and flow cytometry analysis. Results: The results revealed that the MSNPs have a spherical shape with an average dimension, pore size, and surface area of 56.10 nm, 2.488 nm, and 148.08 m2g-1, respectively. The cell viability results showed higher toxicity of targeted MSNPs in MUC16 overexpressing OVCAR-3 cells as compared to the SK-OV-3 cells; that was further confirmed by the cellular uptake results. The cell cycle analysis exhibited that the induction of sub-G1 phase arrest mostly occurred in MSNP-PEG/SUN-MUC16 treated OVCAR-3 cells and MSNP-PEG/SUN treated SK-OV-3 cells. DAPI staining showed apoptosis induction upon exposure to targeted MSNP in MUC16 positive OVCAR-3 cells.  Conclusion: According to our results, the engineered NSs could be considered an effective multifunctional targeted drug delivery platform for the mucin 16 overexpressing cells.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Ovarian cancer</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Mucin 16 aptamer</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Mesoporous silica nanoparticles</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Targeted drug delivery</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Sunitinib</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>